Betel‐quid addictive use disorders and Oral potentially malignant disorders and Oral cancer in south, southeast, and East Asia: A systematic review and meta‐analysis
Oral Diseases · 2025-05 · 31 (5) · 1517-1530
DOI: 10.1111/odi.15106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oral Diseases, online erschienen am 20.08.2024. Verfasst von Albert Min-Shan Ko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department and Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Areca, Substance-Related Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: The Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program withi….
Abstract (Originalsprache)
Objective
This study aimed to provide a comprehensive assessment of the measurement and prevalence of betel‐quid (BQ) abuse, dependence, and BQ use disorder (BUD), as well as to evaluate the impact of BQ addiction on oral malignant diseases.
Methods
We used the PRISMA guidelines to perform a systematic review and meta‐analysis. We searched for relevant publications up to April 2024 in PubMed, Web of Science, and Embase. The articles were evaluated for BQ addiction and its relationship with oral potentially malignant disorders (OPMD) and oral cancer.
Results
The prevalence of BQ abuse, dependence, and BUD in South, Southeast, and East Asia varied between 0.8%–46.3%, 0.4%–43.5%, and 4.7%–39.2%, respectively. Among BQ chewers, the corresponding proportions of these disorders ranged from 40.5%–99.6%, 20.9%–99.6%, and 55.2%–99.3%. The pooled risks of OPMD associated with BQ abuse, dependence, and BUD were 16.3, 18.7, and 9.6–35.5, respectively. The risk of oral cancer for mild, moderate, and severe BUD was 8.5, 8.2, and 42.3, respectively.
Conclusions
BUD mediates the link between BQ use and an increased risk of oral malignant disorders. Addressing and treating BQ addiction is an important component of comprehensive OPMD and oral cancer preventive and intervention programs that go beyond simple cessation efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department and Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.
- Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan.
- Cardiovascular Department, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Social, Behavioral, and Population Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
- Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Albert Min-Shan Ko, Pei-Wen Wu, Wei-Ting Lin, Chien-Hung Lee
Förderung
- The Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program withi…
Zitieren
APA
Ko, A. M., Wu, P. W., Lin, W. T., & Lee, C. H. (2025). Betel‐quid addictive use disorders and Oral potentially malignant disorders and Oral cancer in south, southeast, and East Asia: A systematic review and meta‐analysis. Oral Diseases, 31(5), 1517-1530. https://doi.org/10.1111/odi.15106
Vancouver
Ko AM, Wu PW, Lin WT, Lee CH. Betel‐quid addictive use disorders and Oral potentially malignant disorders and Oral cancer in south, southeast, and East Asia: A systematic review and meta‐analysis. Oral Diseases. 2025;31(5):1517-1530. doi:10.1111/odi.15106
BibTeX
@article{Ko2025,
author = {Ko, Albert Min-Shan and Wu, Pei-Wen and Lin, Wei-Ting and Lee, Chien-Hung},
title = {Betel‐quid addictive use disorders and Oral potentially malignant disorders and Oral cancer in south, southeast, and East Asia: A systematic review and meta‐analysis},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {5},
pages = {1517--1530},
doi = {10.1111/odi.15106}
}
EUVIMED